InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Bertolini Robert J, 董事. Director active across 2 companies, notably CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Cumulatively, 4 reports have been recorded. Activity tracked since 7 May 2021. The latest transaction was filed on 13 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bertolini Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
559 股@ US$228.41100.0% 占其流量Common StockSEC:0001127602-24-015525:0
664 股0Common StockSEC:0001127602-23-015842:0
575 股0Common StockSEC:0001127602-22-014401:0
355 股0Common StockSEC:0001127602-21-016100:0
4 条申报中的 4 条
About Bertolini Robert J
Robert J. Bertolini serves as a Board Member at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. He brings expertise in biotechnology and business management. As a board member, he plays a key role in strategic direction and oversight of the company's performance. His experience in the healthcare sector is an asset in guiding CHARLES RIVER towards innovation and growth.
